QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO’s VGX-3100 for Advanced Cervical Dysplasia
Go back to QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO’s VGX-3100 for Advanced Cervical Dysplasia| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 10.37 +0.35 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.02 | 52 Week High | $11.69 | |||
| Open | $9.95 | 52 Week Low | $4.50 | |||
| Day High | $10.82 | P/E | N/A | |||
| Day Low | $9.95 | EPS | $-0.28 | |||
| Volume | 242,484 | |||||
| Qiagen NV (NYSE: QGEN) | Delayed: 41.89 +0.67 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.22 | 52 Week High | $28.50 | |||
| Open | $41.28 | 52 Week Low | $19.94 | |||
| Day High | $41.94 | P/E | 144.45 | |||
| Day Low | $41.19 | EPS | $0.29 | |||
| Volume | 971,222 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
